Stocks To Buy Now

Blog


FinovateEurope 2024 To Feature Pioneering Fintech Innovations

Finovate is Europe’s leading fintech conference that offers a phenomenal platform for companies and executives. They come together at Finovate to discover and discuss innovative ideas and develop impactful connections in various fintech verticals. Get important insights as experts delve deep into vital and trending topics of the fast developing fintech world.

At Finovate, you see the best operational strategies from financial influencers. Fintech firms and entrepreneurs must leverage this huge opportunity to develop networking ties with investors, bankers, and key financial innovators.

Attendees get immense exposure as over 1,000 decision-makers with 100+ expert speakers and 500+ financial institutions will be a part of this two-day conference. Representatives from banks and financial institutions include giant firms such as Lloyds Banking Group, Citi, BNP Paribas, Bank of America, HSBC, Barclays, JP Morgan Asset Management, Commerzbank, and more.

Around 35 startups, upcoming firms as well as established firms across Europe, will provide 7-minute demos highlighting their financial services and the newest tech ideas. Avoiding slides and videos, they will offer a quick informative vision, an efficient way to be introduced to the latest offerings.

The lineup of demo sessions includes players from the fintech spectrum across retail banking, sustainability, business banking, wealth management, and more. 89% of the companies will showcase demos at Finovate for the first time. 71% have chosen the finovate platform for launching new companies or technology. The best demo sessions also have a chance to win the Best Of Show award.

Finovate sessions are well-curated to create the maximum impact and offer high returns to those participating in the event. Connect with top innovators and regulators who have shaped several financial services globally over drinks, lunches, demo breaks, and more.

To know more, please visit https://ibn.fm/BTFPR

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year

February 12, 2026

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity […]

Rotate your device 90° to view site.